We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.58B
AUM Growth
+$204M
Cap. Flow
+$132M
Cap. Flow %
8.36%
Top 10 Hldgs %
23.89%
Holding
2,171
New
704
Increased
364
Reduced
496
Closed
552

Sector Composition

Rank Sector Weight
1 Technology 16.36%
2 Healthcare 10.17%
3 Financials 8.41%
4 Communication Services 7.7%
5 Energy 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTSI
1176
DELISTED
FTS International, Inc. Common Stock
FTSI
$39K ﹤0.01%
136
-74
-35% -$27K
AAL icon
1177
CALL
American Airlines Group
AAL
$10.6B
$38K ﹤0.01%
+1,000
New +$44.1K
IOVA icon
1178
PUT
Iovance Biotherapeutics
IOVA
$2.87B
$38K ﹤0.01%
3,000
LVS icon
1179
PUT
Las Vegas Sands
LVS
$29.6B
$38K ﹤0.01%
+500
New +$38.2K
OFIX icon
1180
Orthofix Medical
OFIX
$419M
$38K ﹤0.01%
665
+465
+233% +$26.5K
PRGS icon
1181
Progress Software
PRGS
$1.76B
$38K ﹤0.01%
985
-5,815
-86% -$221K
RFIL icon
1182
RF Industries
RFIL
$139M
$38K ﹤0.01%
+5,200
New +$32.5K
RHI icon
1183
Robert Half
RHI
$4.37B
$38K ﹤0.01%
582
-4,511
-89% -$286K
VRDN icon
1184
Viridian Therapeutics
VRDN
$2.67B
$38K ﹤0.01%
400
+67
+20% +$7.08K
SGI
1185
PUT
Somnigroup International
SGI
$13.7B
$38K ﹤0.01%
+3,200
New +$37.7K
AMR
1186
DELISTED
Alta Mesa Resources Inc
AMR
$38K ﹤0.01%
+5,630
New +$40.7K
CCRN
1187
DELISTED
Cross Country Healthcare
CCRN
$37K ﹤0.01%
+3,246
New +$38.7K
GKOS icon
1188
Glaukos
GKOS
$10.6B
$37K ﹤0.01%
900
-600
-40% -$21.3K
GSIT icon
1189
GSI Technology
GSIT
$258M
$37K ﹤0.01%
4,934
+3,144
+176% +$23.7K
HII icon
1190
Huntington Ingalls Industries
HII
$12.8B
$37K ﹤0.01%
172
-297
-63% -$69K
ITW icon
1191
Illinois Tool Works
ITW
$84.5B
$37K ﹤0.01%
266
-2,824
-91% -$418K
PATK icon
1192
Patrick Industries
PATK
$2.85B
$37K ﹤0.01%
969
+546
+129% +$21.5K
LTRPA
1193
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$37K ﹤0.01%
+2,301
New +$29.8K
LMNX
1194
DELISTED
Luminex Corp
LMNX
$37K ﹤0.01%
1,262
-5,116
-80% -$131K
RTEC
1195
DELISTED
Rudolph Technologies Inc
RTEC
$37K ﹤0.01%
1,249
-57
-4% -$1.73K
CBRE icon
1196
CBRE Group
CBRE
$42.9B
$36K ﹤0.01%
+748
New +$35.4K
E icon
1197
ENI
E
$77.5B
$36K ﹤0.01%
+970
New +$36.4K
FCX icon
1198
Freeport-McMoran
FCX
$97.5B
$36K ﹤0.01%
2,108
-29,758
-93% -$505K
MOH icon
1199
Molina Healthcare
MOH
$10.3B
$36K ﹤0.01%
363
-1,072
-75% -$93.4K
TEVA icon
1200
Teva Pharmaceuticals
TEVA
$41.2B
$36K ﹤0.01%
+1,494
New +$30.5K

Similar funds

Prelude Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Prelude Capital Management held 2,171 positions worth $1.58B, up 15% from $1.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Prelude Capital Management deployed $132M of net new capital in Q2 2018, opening 704 new positions and adding to 364 existing holdings. Its largest new stake was Mitel Networks Corporation: 1,801,655 shares worth $19.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Micron Technology, an estimated $9.59M trimmed.

  • Prelude Capital Management's largest Q2 2018 buy was Mitel Networks Corporation: 1,801,655 shares worth $19.8M.
  • Prelude Capital Management added most to Twenty-First Century Fox, Inc. Class B in Q2 2018, an estimated $24M increase.
  • Prelude Capital Management's biggest Q2 2018 reduction was Micron Technology, cutting an estimated $9.59M.
  • Prelude Capital Management fully exited Time Warner Inc in Q2 2018, selling an estimated $38.9M.
  • Prelude Capital Management's ten largest holdings make up 24% of its $1.58B portfolio in Q2 2018.
  • Prelude Capital Management opened 704 new positions and closed 552 in Q2 2018.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Prelude Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.